• Menu
  • Menu
  • World
  • World
  • UAE
  • Opinion
  • Subscribe
  • Logout
Trending
UAE holidays 2021 Coronavirus Special Reports Find Jobs in the UAE Travel
  • Latest News
  • UAE
    • Crime
    • Education
      • Young Editors
    • Environment
    • Government
    • Health
      • Better Health
      • Why Worry
    • Transport
    • Science
    • Ramadan
    • Weather
    • Reader Complaint
    • Ask the Law
    • UAE's Hope Probe
  • Living In UAE
    • Visa+Immigration
    • Housing
    • Phone+Internet
    • Banking
    • Transport
    • Health
    • Education
    • Relocate
    • Ask Us
    • Safety+Security
  • Gulf
  • Your Money
    • Saving and Investment
    • Budget Living
    • Taxation
    • Expert Columns
    • Community Tips
  • Business
    • Banking
    • Aviation
    • Property
    • Energy
    • Analysis
    • Tourism
    • Markets
    • Retail
    • Company Releases
  • World
    • Gulf
      • Bahrain
      • Kuwait
      • Oman
      • Qatar
      • Saudi
      • Yemen
    • Mena
    • Europe
      • Brexit
    • Africa
    • Americas
      • US Presidential Elections 2020
    • Asia
      • India
      • Pakistan
      • Philippines
    • Oceania
    • Offbeat
    • Court and Crime
    • Coronavirus
    • Infographics
  • Opinion
    • Editorials
    • Op-Eds
    • Letters
    • Off the Cuff
    • Cartoons
    • From the Editors
  • Sport
    • UAE Sport
    • Horse Racing
      • Dubai World Cup
    • Cricket
      • IPL
        • Chennai
        • Delhi
        • Punjab
        • Kolkata
        • Mumbai
        • Rajasthan
        • Bangalore
        • Hyderabad
        • Schedule
        • Live Scores
        • Point Table
        • Top Scorers
      • ICC
    • Football
    • Motorsport
    • Tennis
      • Dubai Duty Free Tennis 2020
    • Golf
    • Rugby
  • Entertainment
    • Hollywood
    • Bollywood
    • Pakistani Cinema
    • Pinoy Celebs
    • South Indian
    • Arab Celebs
    • Music
    • TV
    • Books
    • Theatre
    • Arts+Culture
  • Going Out
    • Movie Reviews
    • Society
  • Photos
    • News
    • Entertainment
    • Readers' Photos
    • Lifestyle
    • Business
    • Sports
  • Parenting
    • Pregnancy & Baby
    • Learning & Play
    • Child Health
    • For Mums & Dads
    • Ask Us
  • DUNS100
  • Auto
    • News
    • Test Drives
    • Car Culture
    • Auto Care
  • Lifestyle
    • Health+Fitness
      • Beating Breast Cancer
    • Family
    • Community
      • India
      • Pakistan
      • #Pinoy
    • Home
    • Fashion
    • Weekend Review
  • GN Reach
  • Jobs
  • Tech
    • Electronics
      • Gitex Shopper
    • Gaming
    • Trends
    • Fin-Tech
    • Media
  • How To
    • Employment
      • Jobs
    • Passports & Visas
    • Your Money
    • Legal
  • Videos
    • How-To
    • Best Of Bollywood
    • News
    • Entertainment
    • Business
    • Sport
    • #Pinoy
    • Community
    • Travel
    • Technology
  • GN Focus
  • Bayat Chapters
  • Travel
    • Destinations
    • Hotels
  • Gold-Forex
  • Notifications
  • Gold/Forex
  • Prayer Times
  • Cinema Listing
  • About Gulf News
  • Contact us
  • Work with us
  • Terms and Conditions
  • Privacy Policy
  • Gulf News store
  • Advertise with us
  • Reach by GN
  • GN Focus
  • Gulf News epaper
  • Sitemap
  • Have your say
  • © Al Nisr Publishing LLC 2021. All rights reserved.
    Revealed: Prices of some leading COVID-19 vaccine candidates

    World

    Login / Sign Up
    Logout
    Sunday, April 11, 2021
    Gold / Forex

    World

    • Gulf
    • Mena
    • Europe
    • Africa
    • Americas
    • Asia
    • Oceania
    • Offbeat
    • Court and Crime
    • Coronavirus
    • Infographics
    All Sections

    Revealed: Prices of some leading COVID-19 vaccine candidates

    Vaccine makers reveal prices of their jabs undergoing final human trials


    Published:  August 23, 2020 18:03 Last updated:  November 16, 2020 16:30 Jay Hilotin, Senior Assistant Editor

    1 of 10
    Gulf News
    LEADING THE RACE: At least 10 vaccine candidates from around the world are in late-stage (Phase 3) clinical trials, out of 150 or so COVID-19 vaccines in development. The virus has kicked up a global economic meltdown, with 51 million coronavirus cases and 1.26 million deaths recorded as of November 10, 2010. With millions of jobs lost, a heightened sense of altruism has emerged, as tens of thousands of vaccine trial volunteers were recruited relatively quickly. Hyper collaboration between scientists and health authorities is driving vaccine development, enabled by cloud computing. These factors, absent in the previous era of vaccine makers, help speed up vaccine trials today, compared to previous pandemics. It typically takes 4 years to develop a vaccine. But this time, hopes are high that at least one shot could hit the market in record time, without compromising safety and efficacy. Image Credit: File / Gulf News
    2 of 10
    Modern MRNA mRNA-1273
    $32- $37 - MESSENGER RNA: Moderna announced on Monday (November 16, 2020), that their COVID-19 vaccine is vaccine "94.5% effective". The Massachusetts-based biotech company is working in collaboration with the US National Institutes of Health. This new type of vaccine relies on injecting components of a virus’s genetic material, a messenger RNA (mRNA), into human cells. Unlike other vaccines, it doesn't use an actual virus. Instead, it creates viral proteins that mimic the coronavirus. As such it trains the human immune system to get activated. The vaccine technology is a new, unproven platform that had been under development since the 1990s. If it succeeds, however, mRNA-1273 would be the first such vaccine approved for human use. How mRNA vaccine works: https://gn24.ae/9f1d22dc3395000 Image Credit: AFP
    3 of 10
    Pfizer vaccine BNT162b2
    $19.50 - SUPPLY CONTRACT SIGNED: The vaccine project of New York-based Pfizer and German biotech company BioNTech is also based on the mRNA platform. It was developed by the German company’s earlier efforts on experimental cancer treatment. On July 27, 2020, they started the BNT162b2 trial which combines Phases 2 and 3 by enrolling 30,000 people from 39 US states and from Brazil, Argentina, and Germany. Pfizer has signed a $1.95 billion supply contract with the US government to provide 100 million doses by December 2020. The deal kicks in when and if the drug is approved by the US Food and Drug Administration (FDA). Following the interim analysis showing the drug is 90% effective, Pfizer now reportedly seeking emergency use authorization (EUA) from the FDA by end-November 2020. Image Credit: Reuters
    4 of 10
    Oxford vaccine
    $4 - SHOT FROM OXFORD: AZD1222, also known as the ChAdOx1 nCoV-19, is the vaccine developed by researchers at the University of Oxford’s Jenner Institute. On August 22, 2020, they started enrolling subjects in a phase 2/3 clinical trial of AstraZeneca-partnered COVID-19 vaccine. The project completed a 1,000-subject Phase 1, and now working on a 40,051-subject Phase 3 in the UK. A Phase 3 clinical trial listing [https://clinicaltrials.gov/ct2/show/NCT04516746] shows “study completion date” by October 25, and “primary completion date” by December 22, 2020. Image Credit: Supplied
    5 of 10
    Sinopharm's New Crown
    $145 FOR TWO SHOTS*: Sinopharm's China National Biotec Group (CNBG), a state-owned pharmaceutical company, says that its COVID-19 vaccine will reach market by December. “It is expected to cost a few hundred yuan for a shot, and for two shots it should be less than 1000 yuan ($145),” Sinopharm CEO Liu Jingzhen, told Guangming Daily. On July 26, 2020, the Phase 3 trial for the SinoPharm vaccine kicked off in Abu Dhabi, UAE, which quickly signed up thousands. About 31,000 volunteers took part in the UAE Phase 3 vaccine trials as of end-August 2020. It was the world's first Phase 3 clinical trial of the COVID-19 "inactivated" vaccine platform. Image Credit: CNBG
    6 of 10
    Sinovac Biotech's CoronaVac
    INACTIVATED VACCINE: Sinovac Biotech's CoronaVac SARS-CoV-2 Vaccine candidate is based on an inactivated pathogen. A phase 3 clinical trial aims to recruit 9,000 people, mostly healthcare professionals, working in COVID-19 specialised facilities in 12 clinical sites, located in several states in Brazil. No price was given by the developers yet. Image Credit: Xinhua
    7 of 10
    Cansino Ad5-nCoV vaccine
    APPROVED FOR USE IN THE CHINESE MILITARY: The Ad5-nCoV vaccine candidate is a genetically engineered vaccine candidate with the adenovirus type 5 as the "vector" (carrier) to express SARS-CoV-2 spike protein. The vaccine candidate is built upon CanSinoBIO’s adenovirus-based viral vector vaccine technology platform. The vaccine was co-developed by the Beijing Institute of Biotechnology. On June 29, 2020, China's Central Military Commission gave its approval for Ad5-nCoV to be used in the Chinese military from one year. Image Credit: File
    8 of 10
    Serum Institute
    $13.20 - READY FOR MASS PRODUCTION: Serum Institute, an Indian biotech firm and the world's largest vaccine maker by volume, is girding up for hundreds of millions of shots. It envisages a price of Rs1,000 ($13.20) per shot, though governments may give it to their people without charge, said Serum Institute's Cyrus Poonawalla. According to Suresh Jadhav, Executive Director of SII, the vaccine maker will start manufacturing the vaccine the moment the Phase-3 trial or the combined Phase-2/Phase-3 trial begins. Image Credit: Oxford
    9 of 10
    Sputnik V Gamaleya
    PARTNERSHIP WITH INDIA: On August 11, 2020, Russian President Vladimir Putin said Russia’s Sputnik V was the “world's first vaccine against COVID-19”. Developed by Gamaleya Research Institute of Epidemiology and Microbiology, Sputnik V is reportedly “90%” effective and forms a "stable immunity" against the disease. Kirill Dmitriev, the CEO of the Russian Direct Investment Fund (RDIF), who developed the shot with Gamaleya, said they have tied up with India's Dr. Reddy’s Laboratories to conduct the clinical trials and distribution of Sputnik V vaccine in India. RDIF will supply 100 million doses of the COVID-19 vaccine to Dr. Reddy’s. The Sputnik V based on the adenoviral vector platform. If the trials succeed the vaccines will be available in India as early as November this year. No price was given yet for the Russian vaccine. Image Credit: AFP
    10 of 10
    Gavi vaccine price drop
    PRICE DROP: Prices of vaccines eventually drop over time. There's also a growing evidence that the GAVI Vaccine Alliance is helping bring down prices for vaccines. This happened for hepatitis B, DTP-hepB and one-in-five pentavalent vaccines. Graph shows Price decline of hepatitis B vaccines. Under a new landmark collaboration between the Serum Institute of India (SII), Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation announced on August 7, 2020, manufacturing and delivery of up to 100 million doses of future safe and effective COVID-19 vaccines will be accelerated for low- and middle-income countries in 2021. Image Credit: Gavi/UNICEF Supply Division, 2010

    Trending

    • Ramadan 2021: Moon sighting committee to meet tonight

      Ramadan 2021: Moon sighting committee to meet tonight


    • Man divorces wife because she got COVID-19 thrice

      Man divorces wife because she got COVID-19 thrice


    • Prime Minister Imran Khan’s Anti-Rape Ordinance 2020

      Prime Minister Imran Khan’s Anti-Rape Ordinance 2020


    • Oman: New electronic visa service system activated

      Oman: New electronic visa service system activated


    • Why are COVID-19 cases rising in India?
      Explainer

      Why are COVID-19 cases rising in India?


    • Saudi man arrested for killing muezzin, worshipper

      Saudi man arrested for killing muezzin, worshipper

    Latest In

    • Post-COVID-19 era of hybrid work beckons in UK

      46 minutes ago

    • Myanmar's post-coup civilian death toll climbs past 700

      51 minutes ago

    • Saudi Arabia: Taraweeh prayers shortened in Ramadan

      55 minutes ago

    • Strong reactions on Kerala couple’s viral dance video

      1 hour ago

    • Saudi Arabia announces first day of Ramadan 2021

      1 hour ago

    Go back to top
    Network links:
    • Baby & Child
    • Friday
    • Inside Out
    • Watch Time
    • Wheels
    • getthat
    • GN Tech
    • Jobs
    • About Gulf News
    • Contact us
    • Work with us
    • Terms and Conditions
    • Privacy Policy
    • Gulf News store
    • Advertise with us
    • Reach by GN
    • GN Focus
    • Gulf News epaper
    • Sitemap
    • Have your say
    Find us on Social
    © Al Nisr Publishing LLC 2021. All rights reserved.
    This website stores cookies on your computer. These cookies are used to improve your experience and provide more personalized service to you. Both on your website and other media. To find out more about the cookies and data we use, please check out our Privacy Policy.
    Share on Facebook
    Share on Twitter
    Share on Whatsapp
    Share on Mail
    Share on LinkedIn
    Close
    Gulf News

    Get Breaking News Alerts From Gulf News

    We’ll send you latest news updates through the day. You can manage them any time by clicking on the notification icon.

    Subscribe No Thanks
    Continue reading Gulf News
    Dear Reader, please register to read gulfnews.com

    Dear Reader,

    This section is about Living in UAE and essential information you cannot live without.

    Register to read and get full access to gulfnews.com

    Create your account
    or login if you already have one
    First name is required.
    Last name is required.
    Please enter a valid email address.
    Password should have minimum 7 characters with at least one letter and number
    Passwords do not match

    By clicking below to sign up, you're agreeing to our Terms of Use and Privacy Policy

    Login your account
    New to Gulf News? Sign up now
    Please enter your email address.
    Please enter your password.

    Forgot password

    or